PEG -P[Gu]
|
Poly(ethylene glycol)-poly(glutamic acid) |
Akt
|
Protein kinase B |
ANK
|
Ankyrin repeats |
APC
|
Adenomatous polyposis coli |
AREG
|
Amphiregulin |
ATM
|
Ataxia telangiectasia mutated |
ATR
|
Ataxia-telangiectasia and Rad3 related |
Bax
|
B-cell lymphoma associated X protein |
BCl-2
|
B-cell lymphoma |
BLM
|
Bleomycin |
BRCA1
|
Breast cancer type 1 gene |
CA9
|
Carbonic anhydrase 9 |
CDF
|
Curcumin-difluorinated |
c-Met
|
Mesenchymal-epithelial transition factor |
CSCs
|
Cancer stem cells |
CTCs
|
circulating tumor cells |
ctDNA
|
Circulating tumor DNA |
DDAB
|
Dimethyl octadecyl ammonium bromide |
DDP
|
Cisplatin |
DL
|
Delta-like |
EBV
|
Epstein-Barr virus |
ECD
|
Extracellular domain |
EGFR
|
Epidermal growth factor receptor |
EMT
|
Epithelial-mesenchymal transition EMT |
ERK
|
Extracellular signal-regulated kinase |
EVs
|
extracellular vesicles |
FA
|
Folate |
FBXW7
|
F-Box and WD repeat domain containing |
FGF2
|
Fibroblast growth factor-2 |
FR
|
Folate receptor |
Gab1
|
Growth factor receptor bound protein 2 associated binder 1 |
GLUT1
|
Glucose transporter 1 |
GNR
|
Gold nanorods |
GNS
|
Gold nanoshells |
GSK-3β
|
Glycogen synthase kinase-3-β |
HCV
|
Hepatitis C virus |
HGF
|
Hepatocyte growth factor |
HIF-1α
|
Hypoxia-inducible factor-1α |
HIOEC
|
Human immortalized oral epithelial cells |
HMGA2
|
High mobility group protein 2 |
HNSCCs
|
Head and neck squamous cell carcinomas |
HPV
|
Human papilloma virus |
HT
|
Hyperthermia |
IGF-1R
|
Insulin-like growth factor-1 receptor |
iNOP
|
Interfering nanoparticles |
IRS-1
|
Insulin receptor substrate-1 |
JAG
|
Jagged |
JAK
|
Janus kinase |
KRAS
|
Kirsten rat sarcoma 3 |
Leuk1
|
Precancerous leukoplakia |
Ma
|
Macrophages |
MAPK
|
Mitogen-activated protein kinase |
MDC1
|
Mediator of DNA damage checkpoint 1 |
MiRNAs
|
MicroRNAs |
MNPs
|
Superparamagnetic nanoparticles |
MOFs
|
Metal-organic frameworks |
MRI
|
Magnetic resonance imaging |
MSV
|
Multi-stage vector |
mTOR
|
Mammalian target of rapamycin |
NGOs
|
Non-graphene oxide nanoparticles |
NGS
|
Next-generation sequencing |
NICD
|
NOTCH intracellular domain |
NIR
|
Near-infrared |
NLCs
|
Nanostructured lipid carriers |
NM
|
Nanomedicine |
NMs
|
Nanomaterials |
NOCTH
|
Neurogenic locus notch homolog protein |
NS
|
Normal saline |
OSCC
|
Oral squamous cell carcinoma |
p53
|
Tumor protein p53 |
p53BP1
|
p53 binding protein 1 |
p63
|
Tumor protein p63 |
PAA
|
Polyacrylic acid |
PDK1
|
Phosphoinositide-dependent protein kinase 1 |
PDT
|
Photodynamic treatment |
PEG
|
Polyethylene glycol |
PGK
|
Phosphoglycerate kinase |
PHM
|
Pleckstrin homology motif |
PI3K
|
Phosphatidylinositol 3-kinase |
PIP2
|
Phosphatidylinositol 4,5-bisphosphate |
PIP3
|
Phosphatidylinositol 3,4,5-triphosphate |
PPTT
|
Plasmonic photothermal therapy |
PRGR
|
Peptide-releasing gastrin receptor |
PTEN
|
Phosphatase and tensin homolog |
PTKM
|
Protein tyrosine kinase motif |
PTX
|
Paclitaxel |
QDs
|
Quantum dots |
RM
|
Relapsed metastatic |
ROS
|
Reactive oxygen species |
RT
|
Radiotherapy |
SalB
|
Salvianolic acid B |
SEMA
|
Semaphorin |
SHP2
|
SH2-containing protein tyrosine phosphatase |
SiAuNS
|
Silica-gold nanoshells |
STAT3
|
Signal transducers and activators of transcription-3 |
TACE
|
TNF-α converting enzyme |
TAFs
|
Tumor-associated fibroblasts |
TAM
|
Transcriptional activation motif |
TGF-β
|
Transforming growth factor beta |
TNM
|
Tumor nodal metastasis |
TYK
|
Tyrosine kinase |
VEGF
|
Vascular endothelial growth factor |
α-TOS
|
alpha-tocopheryl succinate |